Shri Shetty, MBA
Chief Executive Officer
Pioneering value-based business strategies that expand global market access for ISO 13485 certified orthopaedic products.
Rethinking Orthopedic Supply Chains
Engineered for Precision. Priced for Value. Trusted by Overseas Surgeons & Healthcare Procurement Teams Globally.
At the Orthopaedic Implant Company (OIC), we shattered the myth that premium surgical quality must come with inflated price tags. Traditional medical device supply chains burden healthcare systems with excessive overhead and opaque pricing models. OIC disrupts this legacy model by delivering FDA-cleared, ISO 13485:2016 certified orthopaedic trauma systems at costs 50–60% below the industry average—ensuring hospitals and overseas distributors never have to compromise surgical safety for fiscal sustainability.
Purpose
The traditional pricing structure of orthopaedic implants is fundamentally flawed. Our purpose is to eliminate supply chain inefficiencies and make high-performance surgical implants accessible to international healthcare institutions.
Mission
To reduce global healthcare costs by manufacturing trauma implant systems that achieve the optimal balance of clinical quality, surgical ergonomics, and competitive pricing for hospital procurement officers.
Vision
To lead the global movement toward value-based medical technology, empowering medical distributors and surgeons across North America, Asia, Europe, and Latin America with reliable surgical tools.
Executive Leadership & Clinical Advisory
World-Class Expertise in Medical Device Engineering
Our leadership team combines decades of specialized experience in biomedical engineering, orthopedic surgery, international regulatory compliance, and global supply chain management.
Kishore Karkera
Chief Operating Officer
Overseeing global manufacturing operations, quality management systems, and international OEM/ODM logistics fulfillment.
Geoffrey Doyle, MBA
Chief Commercial Officer
Driving strategic distributor partnerships across international markets and hospital buying networks.
Michelle Thai, MD
Chief Strategy Officer
Applying clinical expertise to align product portfolios with real-world surgical requirements and orthopedic trends.
Robert Kamei, MD
Chief Medical Officer (Asia-Pacific)
Leading clinical validation, surgeon training programs, and regional medical advisory boards across Asia-Pacific.
Hamish Thrum, MBA
VP Commercial (ASEAN Region)
Managing Southeast Asian market development, dealer network expansions, and hospital procurement channels.
Partner With a Leading Orthopaedic Implant Manufacturer
Whether you are an international medical distributor seeking exclusive regional distribution rights or a hospital procurement manager evaluating trauma implant costs, OIC is your trusted partner for high-value medtech.